ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 2105

Stratification for elevated urate identifies a pro-inflammatory synovial fluid proteome in knee osteoarthritis: a pilot study

Tuhina Neogi1, Sayali Dhamne2, Robert Terkeltaub3, Virginia Kraus4, Simon Dillon5 and Towia Libermann5, 1Boston University School of Medicine, Boston, MA, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Retired, San Diego, CA, 4Duke University, Durham, NC, 5Beth Israel Deaconess Medical Center, Boston, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: Inflammation, Osteoarthritis, proteomics, Uric Acid, Urate

Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The causes of inflammation, pain fluctuations, and disease progression in osteoarthritis (OA) are not well understood. Soluble urate is a “danger signal”, and synovial fluid urate and IL-18, which along with IL-1β is a product of NLRP3 inflammasome activation, are associated with OA severity on imaging (PMID: 21245324) . In a pilot study, we evaluated differences in proteomic profiles of OA synovial fluid stratified by serum urate among people with OA but without gout to examine potential distinct OA phenotypes. We further explored whether the profiles differed by obesity or age as potential confounders in the association between urate and OA.

Methods: We obtained synovial fluid from individuals with knee OA but without a diagnosis of gout (and on no urate-lowering therapy) who had knee aspirations performed as part of standard clinical care (no crystals detected), and who consented to having their synovial fluid used for this pilot research study. The synovial fluid was immediately stored at 4oC, processed within 4 hours of collection, and then stored at -80oC. The samples were prepared with hyaluronidase and analyzed using the 11k SomaScan v5.0 proteomics assay that measures 10,778 proteins. Differentially expressed proteins were identified by t-tests and further evaluated using XLSTAT statistical software. Systems biology analysis used Ingenuity Pathway analysis (IPA) and STRING to define enriched pathophysiological pathways.

Results: We enrolled 30 participants (mean age 67 ± 11.6, 77% female, mean BMI 32.3 ± 6.9), of whom 47% (n=14) had serum urate >6 mg/dL (Elevated Urate Group (EUG). SomaScan analysis identified 186 proteins associated with the EUG that had an absolute fold change of at least 1.3 and p< 0.05. The top 30 proteins accurately discriminated between EUG and lower urate (Fig.1). IPA (Fig.2a) revealed enrichment of inflammatory response, particularly enhanced activity of the myeloid lineage and phagocytosis as key pathophysiological pathways in the EUG. Upstream regulator analysis confirmed that the predicted regulators with highest statistical significance involved enhanced activity of pro-inflammatory cytokines such as IL-1β and TNF and their downstream signaling mediators such as STAT3 and NFKB1. STRING analysis (Fig.2b) defined clusters of interacting proteins linked to inflammation, acute phase response, complement activation, and mRNA processing as key pathways. BMI-and age-associated protein signatures showed only limited overlap with the hyperuricemia-associated protein signature (Fig.3).

Conclusion: The synovial fluid proteome associated with higher urate in patients with OA included differential upregulation of pathways related to inflammation, phagocytosis, and the complement cascade compared with those whose serum urate was lower than 6.0 mg/dL. Furthermore, the protein signature associated with the EUG had minimal overlap with synovial fluid protein signatures associated with obesity or older age. Elevated urate, a biomarker of OA disease severity, may therefore contribute to an inflammatory profile in OA synovial fluid.

Supporting image 1Figure 1: Hierarchical Clustering of the Top 30 proteins* that had an absolute fold-change of ≥1.3 and p < 0.05 in differentiating the elevated urate group (>6mg/dL) from lower urate group

Supporting image 2Figure 2a: Upstream Regulators identified with Ingenuity Pathways Analysis (IPA) from among the top 30 proteins that had an absolute fold-change of ≥1.3 and p < 0.05 in differentiating the elevated urate group (>6mg/dL) from lower urate group based upon gene expression data. Proteins are listed in ascending order of statistical significance

Figure 2b: Clusters of Protein-Protein Interaction Networks identified with STRING Analysis from among the top 30 proteins that had an absolute fold-change of ≥1.3 and p < 0.05 in differentiating the elevated urate group (>6mg/dL) from lower urate group based upon protein expression data.

Supporting image 3Figure 3: Venn Diagram comparing differentially expressed proteins identified with p < 0.05 in the EUG vs. lower urate group, with differentially expressed proteins based upon obesity (BMI>30 vs. not) or Age (>65 vs. younger), demonstrating minimal overlap.


Disclosures: T. Neogi: None; S. Dhamne: None; R. Terkeltaub: Atom Bioscience, 2, BPG Bio, 2, Crystalys, 2, Novartis, 2, Shanton, 2; V. Kraus: 4-P Pharma, 1, Genascence, 1, Pacira, 1, Paradigm Biopharma, 1; S. Dillon: None; T. Libermann: None.

To cite this abstract in AMA style:

Neogi T, Dhamne S, Terkeltaub R, Kraus V, Dillon S, Libermann T. Stratification for elevated urate identifies a pro-inflammatory synovial fluid proteome in knee osteoarthritis: a pilot study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/stratification-for-elevated-urate-identifies-a-pro-inflammatory-synovial-fluid-proteome-in-knee-osteoarthritis-a-pilot-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stratification-for-elevated-urate-identifies-a-pro-inflammatory-synovial-fluid-proteome-in-knee-osteoarthritis-a-pilot-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology